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Neuroinflammation initiated by damage-associated molecular patterns, including high
mobility group box 1 protein (HMGB1), has been implicated in adverse neurological
outcomes following lethal hemorrhagic shock and polytrauma. Emergency preservation
and resuscitation (EPR) is a novel method of resuscitation for victims of exsanguinating
cardiac arrest, shown in preclinical studies to improve survival with acceptable
neurological recovery. Sirtuin 3 (SIRT3), the primary mitochondrial deacetylase, has
emerged as a key regulator of metabolic and energy stress response pathways in
the brain and a pharmacological target to induce a neuronal pro-survival phenotype.
This study aims to examine whether systemic administration of an Annexin-A1
bioactive peptide (ANXA1sp) could resolve neuroinflammation and induce sirtuin-3
regulated cytoprotective pathways in a novel rat model of exsanguinating cardiac arrest
and EPR. Adult male rats underwent hemorrhagic shock and ventricular fibrillation,
induction of profound hypothermia, followed by resuscitation and rewarming using
cardiopulmonary bypass (EPR). Animals randomly received ANXA1sp (3 mg/kg, in
divided doses) or vehicle. Neuroinflammation (HMGB1, TNFα, IL-6, and IL-10 levels),
cerebral cell death (TUNEL, caspase-3, pro and antiapoptotic protein levels), and
neurologic scores were assessed to evaluate the inflammation resolving effects of
ANXA1sp following EPR. Furthermore, western blot analysis and immunohistochemistry
were used to interrogate the mechanisms involved. Compared to vehicle controls,
ANXA1sp effectively reduced expression of cerebral HMGB1, IL-6, and TNFα and
increased IL-10 expression, which were associated with improved neurological scores.
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ANXA1sp reversed EPR-induced increases in expression of proapoptotic protein Bax
and reduction in antiapoptotic protein Bcl-2, with a corresponding decrease in cerebral
levels of cleaved caspase-3. Furthermore, ANXA1sp induced autophagic flux (increased
LC3II and reduced p62 expression) in the brain. Mechanistically, these findings were
accompanied by upregulation of the mitochondrial protein deacetylase Sirtuin-3, and
its downstream targets FOXO3a and MnSOD in ANXA1sp-treated animals. Our data
provide new evidence that engaging pro-resolving pharmacological strategies such
as Annexin-A1 biomimetic peptides can effectively attenuate neuroinflammation and
enhance the neuroprotective effects of EPR after exsanguinating cardiac arrest.
Keywords: sirtuins, autophagy, apoptosis, neuroprotection, HMGB1
INTRODUCTION
Exsanguinating hemorrhage, leading to cardiac arrest and
multiple organ failure, remains the most common cause of
death among trauma patients without traumatic brain injury,
and neurologic outcomes in survivors are poor. An new
therapeutic paradigm – termed EPR – involves rapidly cooling
victims of exsanguinating cardiac arrest to deep or profound
hypothermia levels (≤20◦C), in an effort to extend ischemic
time, maintain organ viability during severe shock, allow
operative repair of injuries and resuscitation, and ultimately
improve survival and preserve neurological function (Tisherman
et al., 2017). Following initial characterization of EPR, a
growing body of proof-of-concept large animal studies have
investigated the optimal depth and rate of cooling, duration
of EPR, and physiological conditions prior to induction of
EPR (Rhee et al., 2000; Alam et al., 2002, 2004, 2005,
2006a,b; Wu et al., 2006). Rapid cooling and subsequent
controlled resuscitation and rewarming is accomplished through
the use of CPB (Sailhamer et al., 2007; Alam et al., 2008).
The development of rodent models of HS and EPR enabled
characterization of key cellular and molecular changes involved
in exsanguination cardiac arrest (Drabek et al., 2007a,b) – chief
among those are neuroinflammation and apoptosis – which
constitute targets for adjunctive therapies (Han et al., 2008;
Alam et al., 2010).
Neuroinflammation is a complex immune response
commonly observed following acute brain insults such as HS and
associated warm ischemia, ischemia-reperfusion injury (I/RI),
therapeutic hypothermia, exposure to CPB, and post-cardiac
arrest syndrome. Multiple rodent models of surgical trauma,
cardiac arrest and resuscitation have identified upregulation of
pro-inflammatory cytokines and inflammatory mediators in
both peripheral tissues and the central nervous system (CNS)
(Terrando et al., 2010a, 2011). Acute neuroinflammation is
characterized by increased cytokines, such as interleukin-1β
(IL-1β), tumor necrosis factor-α (TNF-α), HMGB1 and
Abbreviations: ANXA1sp, Annexin A1 short peptide; CPB, cardiopulmonary
bypass; EPR, emergency preservation and resuscitation; HMGB1, high mobility
group box 1; HS, hemorrhagic shock; LC3-II, microtubule-associated protein
1A/1B-light chain 3-phosphatidylethanolamine conjugate; MnSOD, manganese
superoxide dismutase; p62/SQSTM1, sequestosome-1; ROS, reactive oxygen
species; SIRT3, sirtuin-3.
their cognate receptors ultimately leading to neuron-glia
dysfunction and blood–brain barrier impairments (Cao et al.,
2010; Terrando et al., 2010b, 2011; He et al., 2012; Liu and
McCullough, 2013; Wohleb et al., 2014; Xiang et al., 2016; Skvarc
et al., 2018). Oxidative stress and mitochondrial dysfunction
converge with the neuroinflammatory pathway, creating
a positive feedback loop (Netto et al., 2018). Collectively,
these mechanisms actively contribute to neuronal death
and cognitive impairment. There is evidence that the
neuroinflammatory milieu persists following surgical trauma,
HS, I/RI, and resuscitation from cardiac arrest because is
not efficiently controlled by endogenous anti-inflammatory
mechanisms, thereby contributing to secondary injury,
CNS dysfunction, and neuronal network hyperexcitability
(Tahsili-Fahadan et al., 2018). Despite improvements in
resuscitation science for victims of HS cardiac arrest, including
EPR, total body cooling is technically and logistically
challenging and the development of effective therapies
to decrease morbidity and improve long-term neurologic
outcomes following exsanguinating cardiac arrest remains
a critical need.
Dysfunction of inflammation-resolving pathways have been
described in experimental rodent trauma models, leading to
exaggerated post-injury cognitive decline (Su et al., 2013). In
recent years, a number of lipid mediators such as resolvins,
lipoxins, and maresins have begun to receive attention as
possible resolvers of neuroinflammation (Terrando et al.,
2013; Vacas et al., 2013). Resolvins act to block neutrophil
and monocyte migration and reduce the oxidative burst
of neutrophils (Serhan et al., 2007; Perretti et al., 2015).
Similarly, the glucocorticoid-regulated protein Annexin A1
and its peptide mimetics display pro-resolution effects, and
have been shown to mitigate cerebral I/RI by attenuating
neuroinflammation in many experimental models (Ansari
et al., 2018) including cardiac surgery with deep hypothermic
circulatory arrest (Zhang et al., 2017). The aim of this study
was to determine the neuroprotective efficacy of a bioactive
Annexin A1 short peptide (ANXA1sp) in a small animal model
of exsanguination cardiac arrest and EPR. We hypothesized
that ANXA1sp treatment would attenuate neuroinflammation
and neuronal cell death, in part through upregulation of
the mitochondrial protein deacetylase SIRT3 and downstream
cytoprotective pathways.
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MATERIALS AND METHODS
Animals
The experimental protocol was approved by the Duke University
Animal Care and Use Committee. All procedures met the
guidelines of the National Institutes of Health for animal care
(Guide for the Care and Use of Laboratory Animals, Health
and Human Services, National Institute of Health Publication
No. 86-23, revised 1996). Adult male Sprague–Dawley rats (age
13–15 weeks; weight 400–450 g; Charles River Laboratories,
Wilmington, MA, United States) were housed (two animals per
cage) in a 12-h light-dark cycle environment with free access to
food and water. Rats were acclimated for at least 1 week before
starting the experiment.
Surgical Preparation for Experimental
EPR
Experimental procedures are summarized in Figure 1. Fasted rats
were anesthetized with isoflurane, intubated, and mechanically
ventilated to maintain the arterial PaCO2 between 35 and
45 mmHg. Anesthesia was provided with isoflurane (1.5–2%)
with an oxygen and air mixture at a FiO2 of 0.5. Bupivacaine
0.25% was injected at the operative sites to achieve local
anesthesia. Routine physiologic parameters, and rectal and
pericranial [hypodermic needle probe (Omega R©, Stamford,
CT, United States) placed beneath the temporalis muscle]
temperatures were monitored. The right caudal epigastric artery
was cannulated with a polyethylene catheter (PE10, Clay Adams,
Sparks, MD, United States) and used for systemic mean arterial
pressure (MAP) monitoring. The tail artery was cannulated
with a 20-gauge catheter, which served as blood sampling
and inflow CPB cannula. The right internal jugular vein
was cannulated with a customized 4.5-F multi-orifice catheter
advanced into the right atrium and used for withdrawing blood
and venous out-flow CPB cannula. The external carotid artery
was cannulated with a polyethylene catheter (PE50; Clay Adams,
Sparks, MD, United States) advanced into the aortic arch and
used for induction of profound hypothermia by flushing ice-cold
normal saline. During surgical preparation, normothermia was
maintained using a heat lamp.
Induction of Hemorrhagic Shock and Ventricular
Fibrillation
After a 30-min equilibration period, rapid exsanguination
(50% blood volume, 0.034 ml/g body weight, 12–15 ml of
blood) over 10 min was performed via the jugular venous
cannula and MAP was allowed to drop below 20 mmHg.
For the next 35 min (simulating pre-hospital transport time),
the MAP remained <20 mm Hg without any resuscitative
efforts HS. The shed blood was salvaged in a 20 ml syringe
prefilled with 2 ml citrate phosphate dextrose solution (Fenwal
Inc., Lake Zurich, IL, United States) and stored at 4◦C for
later transfusion/resuscitation. At the end of HS, ventricular
fibrillation (VF) was induced by transesophageal burst pacing at
50 V (S48 stimulator, RI, United States) for 90 s, and confirmed
electrocardiographically and echocardiographically (Phillips
Sonos7500 system, Andover, Mass 01810). During HS, anesthesia
was maintained using 0.4% isoflurane. No neuromuscular
blocker was administered until just prior to VF. A dose of
vecuronium bromide (0.1 mg/kg) was given intravenously to
prevent muscle contraction during VF and cooling.
Induction of Profound Hypothermia
After the induction of VF, the animals were rapidly cooled
to a core temperature of 10–15◦C for 45 min by flushing
ice-cold solution [total volume 45 ml = 40 ml normal saline
+ 2 ml 5% human plasma protein fraction (Plasmanate R©, Grifols
Therapeutics, Inc., NC, United States) + 3 ml 8.5% Sodium
Bicarbonate] into the ascending aorta/aortic arch and returning
from right jugular vein using a peristaltic pump (Masterflex,
model 770201-60, Cole-Parmer, Vernon Hills, IL, United States)
at rate of 20 ml/kg/min (T208 transonic volume flow meter,
Transonic Systems Inc. Ithaca, NY, United States). A water
bath with ice water as well as topical cooling with ice bags
was also applied.
Resuscitation and Rewarming With Cardiopulmonary
Bypass
Following 45 min of profound hypothermia, rats were rewarmed
and resuscitated using CPB. The CPB circuit consisted of a
peristaltic pump (MasterflexC, Cole-Parmer, Vernon Hills, IL,
United States), a custom-designed oxygenator, and a venous
reservoir, as previously described (Bartels et al., 2014; Shim
et al., 2014; Zhang et al., 2017). The reservoir was primed with
3 ml of 6% hydroxyethylstarch 130/0.4 and 2 ml of previously
shed and salvaged blood. Heparin (200 IU) and vecuronium
bromide (0.1 mg/kg) were added to the venous reservoir. CPB
was initiated at a flow rate of 20–30 ml/min, which was gradually
increased to 50–60 ml/min upon reaching 33–34◦C. The gradient
between the water bath and core body temperatures was not
allowed to exceed 10◦C. Once core temperature increased from
10 to 34◦C, all salvaged blood was gradually re-transfused
to keep up with the increased oxygen demand. The animals
were rewarmed for 80 min until core temperatures of 34◦C
were achieved; subsequently, CPB was terminated. Rewarming
rate was maintained at approximately 0.4◦C/min. Acid-base
abnormalities were corrected as needed. During rewarming,
MAP was kept above 50 mmHg once core temperature reached
>30◦C using intermittent administration of epinephrine.
After decannulation, animals were kept ventilated for 2 h
under anesthesia with 0.5–1% isoflurane (core temperature
36–37◦C). To increase the hematocrit value to greater than
30%, the remaining autologous blood in the CPB circuit was
collected, concentrated by centrifugation (3000 rpm for 5 min),
and re-transfused. Heparin-induced anticoagulation was not
reversed and allowed to dissipate spontaneously. Routine blood
gas analysis was conducted serially (GEM Premier 3000 analyzer,
Instrumentation Laboratory, Bedford, MA, United States). After
spontaneous ventilation had resumed, animals were extubated
and allowed to recover in an oxygen-enriched and humidified
environment for 24 h, with free access to water and food.
To harvest the brain, 24 h after EPR rats were re-anesthetized,
intubated, and mechanically ventilated. One sample of brain
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tissue was immediately fixed in 10% buffered formalin and
paraffin-embedded for immunostaining. The remaining brain
tissue was frozen in liquid nitrogen and stored at −80◦C
until further use. Blood samples were also collected before and
after induction of HS and at 0–120 min and 24 h after CPB
and stored at −80◦C until analysis. Naïve rats were sacrificed
under 5% isoflurane.
Drug Treatments
Annexin A1 biomimetic tripeptide (ANXA1sp or Ac-QAW,
Ac = acetyl, MW = 445.47 Da) was synthesized and
purified (>98% purity) by GenScript (Piscataway, NJ,
United States). The peptide was suspended in 100%
DMSO. For experiments, this stock solution was diluted
in saline to a final dose of 1 mg/kg ANXA1sp and a
concentration of 1% DMSO in saline as vehicle (control).
ANXA1sp treatment solutions were freshly prepared
immediately before use.
Rats were randomly assigned to three groups (EPR +
ANXA1sp, n = 14; EPR+ vehicle, n = 15; naïve controls, n = 3)
and terminated for histologic and biochemical analyses at 24 h
after EPR. Rats received ANXA1sp (1 mg/kg iv) or vehicle (1%
DMSO iv) in 1 ml saline immediately after induction of VF,
then again at 1 h after CPB. Additionally, blood salvaged during
exsanguination HS was also treated ex vivo with ANXA1sp
1 mg/kg or 1% DMSO and re-transfused during CPB rewarming
and resuscitation (Figure 1). All treatments were administered in
a blinded manner.
Cell Death Assessment
Apoptosis was determined by terminal deoxynucleotidyl
nick-end labeling (TUNEL) per assay manufacturer’s protocol
FIGURE 1 | Experimental model of exsanguination cardiac arrest including rapid hemorrhagic shock followed by 90 s of fibrillatory arrest, induction of profound
hypothermia (<15◦C), resuscitation and rewarming on CPB (emergency preservation and resuscitation, EPR) – diagram of surgical model and experimental timeline.
RE, rapid exsanguination; BV, blood volume; HS, hemorrhagic shock; VF, ventricular fibrillation; PH, profound hypothermia; CPB, cardiopulmonary bypass;
ANXA1sp, Annexin A1 short peptide.
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(Roche Diagnostics, Indianapolis, IN, United States). Briefly,
sections of paraffin-embedded brain tissue samples (5 µm thick)
were deparaffinized using xylene and descending grades of
ethanol, and pretreated with microwave radiation (350 W, in
200 mL of 0.1 M Citrate buffer, pH 6.0) for 5 min. Tissue sections
were then incubated with terminal deoxynucleotidyl transferase
(TdT) for 1.5 h at 37◦C and then rinsed with PBS. Slides of
five representative areas of the retrosplenial and posterior
parietal cortex and CA1 area of the hippocampus were mounted
using UltraCruzTMMounting Medium with DAPI (Santa Cruz
Biotechnology, Santa Cruz, CA, United States). Negative controls
were incubated in label solution without TdT. A separate set of
brain tissue sections was stained with acid fuchsin-celestine blue
to identify possible necrotic cells. Cell counting was performed
in a blinded manner across five representative areas of the
cerebral cortex and CA1 areas using fluorescence microscopy
(Leica DM IRB, Germany) with a 20×/0.4 PH objective at
1.5-fold magnification. Data obtained in every field were added
together to make a final data count for each slide and expressed
as percentage of total cell number within the relevant fields.
Western Blots
Frozen brain samples were homogenized and protein quantified
by BCA assay (Thermo Fisher Scientific). Western blotting was
performed using SDS–PAGE 4–20 and 8–16% gels gradient gels
(Bio-Rad) with the following antibodies: rabbit anti-HMGB1
(Bioss Antibodies Inc., Woburn, MA, United States), rabbit
polyclonal antibodies against SIRT3 (28-kDa isoform, Cell
Signaling and Abcam), FOXO3a (Cell Signaling), Mn-SOD
(Santa Cruz), cleaved caspase-3 (Cell Signaling), Bax
and Bcl-2 (Santa Cruz), rabbit anti-LC3B (cell signaling),
mouse anti-p62/SQSTM1 (R&D Systems, Minneapolis, MN,
United States), and rabbit monoclonal antibody against GAPDH
(Cell Signaling Technology, Boston, MA, United States). The
bands were detected by Super-signal West Dura Extended
Duration Substrate (Thermo Scientific Fisher, Rockford, IL,
United States). Band intensities of HMGB1, SIRT3, FOXO3a,
Mn-SOD, cleaved caspase-3, Bax, Bcl-2, LC3II, p62/SQSTM1
were all normalized with a GAPDH loading control.
Cytokine Measurements
Concentrations of IL-10, IL-6, and TNFα in brain homogenates
were measured using rat-specific ELISA kits per manufacturer’s
protocol (Thermo Fisher Scientific, Grand Island, NY,
United States). Brain homogenates were separated by
centrifugation at 14,000 g for 10 min at 4◦C to remove cellular
debris. In addition, left ventricular myocardial concentrations of
IL-6 and TNFα were analyzed by ELISA. Change in absorbance
in every well was detected at 450 nm on a microplate reader. All
measurements were performed in triplicate.
Confocal and Fluorescence Microscopy
After deparaffinization, brain tissue sections were treated with
10 mM citrate buffer (pH 6.0) for antigen retrieval. After
blocking with 10% normal goat serum at RT for 1 h, the
sections were incubated with rabbit anti-SIRT3 antibody (1:300)
and mouse anti-COXIV (1:500, Santa Cruz Biotechnology,
Santa Cruz, CA, United States), or rabbit anti-LC3B (1:400)
and mouse anti-p62/SQSTM1 (1:400), respectively, at 4◦C
overnight. The sections were then incubated with Alexa Fluor
488-conjugated goat anti-rabbit IgG (1:500; Invitrogen, Carlsbad,
CA, United States) and Alexa Fluor 550-conjugated goat
anti-mouse IgG (1:500; Invitrogen, Carlsbad, CA, United States)
at RT for 1 h. After washing with PBS, slides were prepared
and mounted using UltraCruzTM Mounting Medium with DAPI
(Santa Cruz Biotechnology, Santa Cruz, CA, United States)
to detect nuclei. Images were captured on a Leica SP5
confocal microscope (Leica Microsystems, Germany) using a
40×/1.25–0.75 Plan APO oil objective, and the images were
analyzed by NIH ImageJ software (version 1.51).
To assess biodistribution of systemically administered
ANXA1sp, rats were anesthetized, intubated and mechanically
ventilated, and the tail vein cannulated as described above.
Fluorescein isothiocyanate (FITC)-conjugated ANXA1sp
(FITC-QAW, MW = 905.48, >98% purity) was synthesized
and purified by GenScript (Piscataway, NJ, United States) and
injected via the tail vein (0.5 mg/kg). Brain tissue was harvested
at 1 h after injection, fixed with 10% neutrally buffered formalin
and embedded in paraffin. The 5 µm sections were deparaffinized
and evaluated by fluorescence microscopy as above.
Neurologic Evaluation
On postoperative day 1, rats underwent standardized functional
neurologic testing by an observer blinded to group assignment,
using an established neurologic scoring system that evaluates
motor deficit (Homi et al., 2010). Briefly, rats were first placed
on a 35 × 31 cm screen (grid size 0.6 × 0.6 cm) that could be
rotated from horizontal (0◦) to vertical (90◦). The length of time
that the rat could hold onto the screen after being rotated from
0 to 90◦ was recorded to a maximum of 15 s (0–3). Rats were
then tested for balance on a horizontal wooden rod, and the time
lapse before falling off the rod was recorded to a maximum of 30 s
(0–3). Finally, rats underwent a prehensile traction test, and the
length of time that the rat could cling to a horizontal rope was
recorded to a maximum of 5 s (0–3). Animals received a score
for each of the three tests. The final score was the sum of the
individual test scores, with 0 the best score, and 9 the worst score.
Statistical Analysis
Statistical analysis was performed using Prism 8 (GraphPad
Software, San Diego, CA, United States). Results are expressed
as mean± standard deviation (SD). Parametric values, including
physiologic values, data from western blots, ELISA were
compared between groups using one-way analysis of variance
(ANOVA) with post hoc Tukey’s multiple comparison test, or a
Student’s t-test (equal variance not assumed), according to the
characteristics of each experiment. Statistical significance was
defined as p < 0.05.
RESULTS
The 24 h survival rates were 75.0% (9/12) and 61.5% (8/13) for
the ANXA1sp and vehicle treated groups, respectively. One rat
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in vehicle group and three in ANXAsp1 group died from acute
cardiac failure during the early postoperative phase. Additionally,
three rats died of severe spinal cord injury and one of severe brain
injury, all in the vehicle treated group. Two rats in each group
died of technical failures and were excluded from analyses.
Baseline and intraoperative physiological parameters were
similar between groups and are shown in Figures 2A,B and
Table 1. Profound systemic hypotension (MAP < 20 mmHg)
occurred during rapid exsanguination and cardiac arrest
(Figure 2A) and was associated with severe metabolic acidosis
(Table 1). All animals underwent the same cooling and
rewarming protocol (Figure 2B). Rats exhibited spontaneous
hypothermia (from 37◦C to 32◦C) before the onset of systemic
cooling (shock-induced hypothermia). Following induction of
hypothermia, pericranial temperature rapidly dropped to 23◦C
at 5 min (rate of cooling 1.8◦C/min) and to 15◦C at 20 min (rate
of cooling 0.85◦C/min). After 45 min of profound hypothermia
(10–15◦C), animals were resuscitated and slowly rewarmed
FIGURE 2 | Time course of mean arterial pressure (A) and pericranial
temperature (B) during the EPR experimental protocol for vehicle (control) and
ANXA1sp-treated animals. Data presented as mean ± SD (n = 8–9/group).
using CPB to 34–35◦C over 80 min (rate of rewarming
0.4◦C/min).
Systemically Administered ANXA1sp
Traverses the Blood-Brain Barrier and
Attenuates Neuroinflammation After EPR
Relative abundance of HMBG1, a key initiator of
neuroinflammation, was assessed by Western analysis in
brain homogenates. We found a 10% (p < 0.05) attenuation
in cerebral expression of HMGB1 in ANXA1sp compared to
HS-EPR vehicle treated animals (Figures 3A,B). Moreover, brain
levels of the pro-inflammatory cytokines IL-6 and TNFα were
reduced by 55% (p < 0.01) and 27% (p = 0.059), respectively,
with ANXA1sp treatment (Figures 3C,D). Conversely, brain
levels of the anti-inflammatory cytokine IL-10 were increased
by 25% (p < 0.05) in ANXA1sp-treated compared to vehicle
controls at 24 h after EPR (Figure 3E).
Fluorescence-conjugated peptide (FITC-QAW) was
detectable in all areas of brain parenchyma at 1 h following
intravenous injection (Supplementary Figure 1).
Regulation of Cell Death by ANXA1sp
After EPR
Acid fuchsin-celestine blue staining revealed acidophilic neurons
and possible necrosis in the cortex at 24 h after EPR in
vehicle-treated animals, which were reduced by 72% (p < 0.05)
following ANXA1sp treatment (Figures 4A,B). ANXA1sp
treatment was also associated with a 62% (p < 0.05) reduction
in TUNEL-positive cells in the cerebral cortex, but not
in the hippocampus, at 24 h after EPR (Figures 4C,D).
This was corroborated by a 56% (p < 0.05) reduction in
cerebral expression of cleaved caspase-3 in ANXA1sp-treated
animals (Figures 4E,F).
We used Western analysis of brain homogenates to assess
changes in ratios of death and survival factors. At 24 h,
a modest but significant (10%, p < 0.05) increase in the
relative abundance of the anti-cell death protein Bcl-2 was
observed in ANXA1sp compared to vehicle-treated animals
after HS-EPR (Figures 5A,B). Conversely, a marked 5-fold
(p < 0.01) increase in expression of the pro-cell death protein
Bax was seen after HS-EPR in vehicle-treated animals, with
a significant 33% (p < 0.05) reduction following ANXA1sp
treatment (Figures 5A,C). Consequently, the near 5-fold surge
in Bax:Bcl-2 ratio detected after HS-EPR in vehicle-treated
compared to naïve animals (p < 0.001) was attenuated by 38%
(p < 0.01) with ANXA1sp treatment (Figure 5D).
Modulation of SIRT3 Expression and
SIRT3 Pathway by ANXA1sp
Western blot analysis in brain homogenates revealed a 33%
(p < 0.01) reduction in relative abundance of the primary
mitochondrial deacetylase SIRT3 (28 kDa isoform) in
vehicle-treated HS-EPR compared to naïve animals, which
was partially restored with ANXA1sp treatment (increased by
25%, p < 0.05) (Figures 6A,B). Increased SIRT3 expression
with ANXA1sp treatment in both cortical and hippocampal
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TABLE 1 | Physiologic data.
Parameter Group Baseline End of HS End of cooling CPB 30 min CPB 80 min End of CPB 2 h after CPB
pH Vehicle 7.42 ± 0.06 7.19 ± 0.08 7.34 ± 0.09 7.39 ± 0.04 7.45 ± 0.09 7.29 ± 0.08 7.48 ± 0.07
ANXA1sp 7.47 ± 0.04 7.17 ± 0.04 7.27 ± 0.05 7.35 ± 0.06 7.40 ± 0.1 7.32 ± 0.06 7.47 ± 0.05
PaO2 (mmHg) Vehicle 202 ± 46 26 ± 8 46 ± 11∗ 291 ± 47 285 ± 89 240 ± 102 249 ± 77
ANXA1sp 193 ± 26 25 ± 4 31 ± 3 313 ± 40 268 ± 65 253 ± 73 277 ± 131
PaCO2 (mmHg) Vehicle 37.5 ± 6.9 54.8 ± 9. 52.2 ± 11.1 35.6 ± 6.6 34.0 ± 7.8 56.3 ± 13.4 42.2 ± 6.6
ANXA1sp 32.9 ± 4.9 54.4 ± 4.7 57.2 ± 6.1 39.4 ± 5.0 39.3 ± 11.8 50.8 ± 5.1 41.6 ± 4.7
Hct (%) Vehicle 38.00 ± 3.8 33.75 ± 2.4 18.63 ± 1.9 22.29 ± 2.4 23.57 ± 2.9 26.70 ± 4.4
ANXA1sp 38.22 ± 5.5 35.22 ± 2.5 19.00 ± 1.7 23.78 ± 2.0 26.11 ± 5.9 32.50 ± 3.1
BE (mmol/L) Vehicle 0.08 ± 3.6 −7.30 ± 2.9 1.26 ± 4.1 −3.03 ± 3.5 −0.94 ± 2.3 0.16 ± 2.6 6.86 ± 4.5
ANXA1sp 0.47 ± 3.8 −8.57 ± 2.1 −1.69 ± 2.4 −3.46 ± 2.4 −1.31 ± 2.3 −0.51 ± 2.8 6.06 ± 1.8
Results are shown as Mean ± SD; ∗p < 0.05 between groups. ANXA1sp, Annexin A1 short peptide; Hct, hematocrit; BE, base excess; End of HS, at the end of 45 min
of hemorrhagic shock; End of cooling, at the end of 45 min cooling; End of CPB, at the end of cardiopulmonary bypass.
cells was further confirmed by confocal microscopy, with
SIRT3 immunoreactivity colocalizing with the mitochondrial
protein COXIV (Figure 6E). We further measured expression
of FOXO3a and MnSOD, two downstream targets of SIRT3.
EPR resulted in an 87% (p < 0.01) reduction in relative
abundance of the transcription factor FOXO3a and a 42%
(p < 0.001) reduction its regulated antioxidant enzyme MnSOD
compared to naïve animals, and were both partially restored with
ANXA1sp treatment (a 4-fold increase in FOXO3a expression,
p < 0.05; and a 18% increase in MnSOD expression, p < 0.05)
(Figures 6A,C,D).
ANXA1sp Promotes Autophagy
Following EPR
Western blot was performed to detect the expression of
autophagy associated proteins in brain homogenates.
Compared to vehicle, ANXA1sp treatment was associated
with a 35% (p < 0.01) increased expression of LC3II
and a 25% (p < 0.05) reduced expression of p62/SQSTM1
(Figures 7A,B,C). In addition, we detected expression of LC3B
by immunohistochemistry, with LC3B and p62 colocalizing in
cortical cells (Figure 7D).
Neurologic Outcome After EPR and
ANXA1sp Treatment
Finally, we evaluated neurologic changes at 24 h after EPR
and ANXA1sp treatment. Compared to vehicle controls,
ANXA1sp-treated animals had significantly lower neurologic
severity scores, showing improved sensory-motor functions
(including processing involving retrosplenial and posterior
parietal cortex, Figure 4G).
Systemically Administered ANXA1sp
Also Attenuates Myocardial
Inflammation
To evaluate the effects of ANXA1sp in organs that are
not shielded by the blood-brain barrier, we assessed
pro-inflammatory cytokines in left ventricular myocardial
homogenates between groups. At 24 h after EPR, heart
levels of IL-6 and TNFα were reduced in ANXA1sp-treated
animals by 10% (p < 0.05) and 17% (p = 0.054), respectively
(Supplementary Figure 2).
DISCUSSION
In this study, we used a novel experimental model of
acute neuroinflammation triggered by exsanguinating cardiac
arrest and treated by emergent preservation and resuscitation
(EPR) to test the neuroprotective effects and mechanisms of
ANXA1sp administration. Together with our previous findings
that ANXA1sp exerts pro-resolving effects in a rat model of
CPB with global ischemia-reperfusion via deep hypothermic
circulatory arrest (Zhang et al., 2017), we continue to illustrate
how this small peptide impacts neuroinflammation. Here, we
show that ANXA1sp treatment is superior to induction of
profound hypothermia (EPR) alone by increasing cortical cell
viability, promoting a favorable expression of pro-survival (Bcl-2)
versus pro-death (Bax) factors in the brain, reducing caspase-3
activation, and overall improving neurological performance
at 24 h after EPR.
High mobility group box 1 is a key endogenous danger
associated molecular pattern which acts as a mediator of
neuroinflammation resulting from a variety of conditions such
as cerebral ischemia-reperfusion (Kim et al., 2006; Yang et al.,
2011), septic shock, and traumatic brain injury (Parker et al.,
2017). HMGB1 is actively released by neurons and glial cells
upon inflammasome activation, and in turn activates two
pattern recognition receptors on target cells (TLR4 and RAGE)
(Gao et al., 2012), leading to NF-κB mediated production of
pro-inflammatory cytokines (Paudel et al., 2018). HMGB1 also
plays a pivotal role in BBB disruption (He et al., 2012; Festoff
et al., 2016; Yang et al., 2018), either directly via cytokine
mediated activation of metalloproteinase or via disruption of
tight junctions (Gloor et al., 2001; Utech et al., 2010), although
the precise mechanism remains elusive. Nonetheless, altered
BBB permeability is known to then amplify neuroinflammation
and neuronal excitation (Frank et al., 2015, 2016). We provide
primary evidence that HS and exsanguinating cardiac arrest
treated with induction of profound hypothermia and EPR
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FIGURE 3 | Modulation of indices of neuroinflammation after EPR by
experimental group. (A,B) High mobility group protein B1 (HMGB1)
expression in brain homogenates from ANXA1sp-treated animals were
significantly reduced compared to vehicle (controls). (C,D) Cerebral levels of
tumor necrosis alpha (TNFα) and interleukin 6 (IL-6) were increased in the
vehicle controls, and reduced with systemic administration of ANXA1sp.
(E) Cerebral interleukin 10 (IL-10) was significantly reduced after induction of
profound hypothermia (EPR + vehicle) and restored with administration of
ANXA1sp. Data presented as mean ± SD (n = 3–7/group), ∗P < 0.05 and
∗∗P < 0.01 compared to vehicle controls or naïve animals, analyzed by
one-way ANOVA with Tukey’s multiple comparisons test. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
elicit neuroinflammation. Further, we show ANXA1sp treatment
to favorably modulate the neuroinflammatory response, by
attenuating the HS-EPR induced increase in cerebral levels of
the proinflammatory alarmin HMGB1 and altering the balance
of pro-inflammatory (IL-6 and TNFα) and anti-inflammatory
cytokines (IL-10) (Figures 3A–E). This is consistent with
the pleiotropic immunomodulatory functions of IL-10, to
polarize the inflammatory system toward an anti-inflammatory
phenotype (Ip et al., 2017), aiding in the resolution of
neuroinflammation (Garcia et al., 2017). The pro-resolving effects
were accompanied by improved cell survival (Figures 4A–E)
and neurological function (Figure 4G). This study builds on our
previous findings demonstrating beneficial effects of ANXA1sp
on neuroinflammation, microglial activation, NF-κB activation
FIGURE 4 | Necrosis and apoptosis in the CNS after exsanguination cardiac
arrest/EPR and ANXA1sp or vehicle treatment. (A,B) Necrosis, detected by
acid fuchsin-celestine blue, was reduced in the cerebral cortex of ANXA1sp
treated rats. Arrowheads in panel A identify acidophilic neurons in the cortex
and hippocampus (Hpc). (C,D) Terminal deoxynucleotidyl nick-end labeling
(TUNEL) staining and quantification of apoptotic cells. Apoptosis was
significantly reduced in the cerebral cortex of ANXA1sp-treated rats on
postoperative day 1. Arrowheads in panel (C) identify pyknotic positive cells.
Scale bar: 20 µm. (E,F) Western blot analysis of cleaved caspase-3 revealed
significantly reduced levels in brain homogenates from ANXA1sp-treated
animals compared to vehicle (controls). (G) Neurologic score (sensory-motor
function) was significantly improved at postoperative day 1 in ANXA1sp rats.
Data presented as mean ± SD (n = 5–7/group), ∗P < 0.05 and ∗∗P < 0.01
compared to vehicle (controls) analyzed by unpaired t-test (B,D,F) or
Mann–Whitney U-test (G).
and postoperative neurocognitive performance following global
I/RI associated with deep hypothermic circulatory arrest (Zhang
et al., 2017). While our experimental model is complex,
sequentially involving HS, warm cardiac arrest, induction of
profound hypothermia followed by rewarming and resuscitation,
the protective effects of ANXA1sp recapitulate those seen in other
experimental models of cerebral I/RI (Relton et al., 1991; Gavins
et al., 2007; Smith et al., 2015; Vital et al., 2016).
Systemically administered ANXA1sp was also associated with
anti-inflammatory effects in the heart (reduced levels of IL-6 and
TNFα) following HS-EPR. Consistent with previous reports in
experimental models of regional myocardial I/RI (La et al., 2001;
Qin et al., 2015), these results support the broader therapeutic
roles attributed to ANXA1 and its peptide mimetics in reducing
systemic inflammation and conferring organ protection from a
variety of insults involving IR/I.
To better understand the added neuroprotective effects and
mechanisms of action of ANXA1sp in the setting of HS-EPR with
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FIGURE 5 | Western blot analysis of cerebral Bcl-2 and Bax levels after
exsanguination cardiac arrest/EPR and ANXA1sp or vehicle treatment.
Intensities of protein bands corresponding to Bcl-2 (26 kDa) (A,B) and Bax
(23 kDa) (A,C) were measured using computer assisted densitometric
analysis, normalized to the intensity of GAPDH and compared between
experimental groups. ANXA1sp treatment resulted in significantly increased
expression of the anti-apoptotic protein Bcl-2 (B), reduced expression of the
pro-apoptotic protein Bax (C), with a corresponding reduction in the
Bcl-2:Bax ratio (D). Data presented as mean ± SD (n = 3–8/group),
∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 compared to either naïve or vehicle
controls analyzed by one-way ANOVA with Tukey’s multiple comparisons test.
profound hypothermia, we focused on SIRT3, a mitochondrial
protein deacetylase known to be widely and abundantly expressed
in most cell types in the CNS (Kim et al., 2011) and differentially
regulated in brain regions and across stages of development
in the rat (Sidorova-Darmos et al., 2014). SIRT3 is part of
the silent information regulator of transcription (SIRT) family
of NAD+-dependent protein deacetylases, which have emerged
as key regulators of metabolic and energy stress-response
pathways including neuroinflammation (Someya et al., 2010;
Lee et al., 2013; Hattori et al., 2015; Liu L. et al., 2015; Yuan
et al., 2016), but also systemic inflammation (Preyat and Leo,
2013; Vachharajani et al., 2014; Liu T. F. et al., 2015; Traba
et al., 2015). Notably, SIRT3 exerts neuroprotective effects. For
instance, SIRT3 overexpression rescues mutant SOD1-induced
neuronal cell death (Song et al., 2013), increases neuronal
lifespan under mitochondrial oxidative stress (Weir et al.,
2012), protects against excitotoxic injury (Kim et al., 2011),
mediates adaptive neuronal responses (resistance to oxidative
stress, apoptotic cell death) to in vitro bioenergetic, oxidative
and excitatory stress (Cheng et al., 2016), and protects mice
against noise-induced hearing loss in vivo (Someya et al., 2010).
Specifically, SIRT3 has been shown to have a major involvement
in CNS ROS metabolism by regulating FOXO3a transcription
factor and contributing to transactivation of key antioxidant
enzymes including MnSOD and catalase (Rangarajan et al.,
2015). Together, even though results from rodent studies are
not completely consistent (Novgorodov et al., 2016), most data
FIGURE 6 | Cerebral expression of Sirtuin-3 (SIRT3) and downstream
regulated proteins after exsanguination cardiac arrest/EPR and ANXA1sp or
vehicle treatment. (A,B) A significant reduction in SIRT3 (28 kDa short,
processed, active form) was seen after EPR + vehicle treatment compared to
naïve animals, and was rescued in ANXA1sp-treated animals. This was
accompanied by similar expression changes for the forkhead box O3a
(FOXO3a) transcription factor (C), known to transactivate the antioxidant
enzyme manganese superoxide dismutase (MnSOD) (D). GAPDH was used
as loading control (E). At 24 h postoperatively, colocalization of sirtuin-3
(SIRT3) with the mitochondrial protein cytochrome c oxidase complex IV
(COXIV) in cortical and hippocampal slides from ANXA1sp-treated animals
was visualized via double immunofluorescence staining and confocal
microscopy. Data presented as mean ± SD (n = 3–7/group), ∗P < 0.05,
∗∗P < 0.01, and ∗∗∗P < 0.001 compared to either naïve or vehicle controls
analyzed by one-way ANOVA with Tukey’s multiple comparisons test.
suggest that SIRT3 expression is vital for neuronal survival
and suppression of neuroinflammation following physical
stressors. In this study, we noted that relative abundance of
SIRT3 – the 28 kDa processed active isoform, known to
possess deacetylase activity (Schwer et al., 2002; Sundaresan
et al., 2008) – as well as FOXO3a and MnSOD, were all
reduced in brain homogenates following HS-EPR, consistent with
previous reports in experimental models of cerebral I/R (Zhao
et al., 2018), but were rescued with systemic administration
of ANXA1sp (Figure 6). HS, ischemia-reperfusion, and EPR
incite neuroinflammation, and SIRT3-mediated upregulation
of FOXO3a-dependent antioxidant gene expression could be
Frontiers in Neuroscience | www.frontiersin.org 9 June 2019 | Volume 13 | Article 608
fnins-13-00608 June 13, 2019 Time: 17:39 # 10
Ma et al. ANXA1 and Resolution of Neuroinflammation
FIGURE 7 | ANXA1sp promotes cerebral autophagy after exsanguinating
cardiac arrest/EPR. The expression of LC3II and p62/SQSTM1
(sequestosome 1) was assessed by western blot and normalized to GAPDH
(A–C). (D) Colocalization of LC3B with p62 in cortical and hippocampal slides
from animals treated with ANXA1sp and vehicle (controls) was visualized by
double immunofluorescence staining and confocal microscopy. Increased
number of LC3B positive/p62 positive puncta appears in the
ANXA1sp-treated group. ∗∗p < 0.01; ∗p < 0.05.
implicated in the attenuation of ROS neurotoxicity associated
with acute neuroinflammation and activation of microglia.
This may translate into attenuation of secondary brain injury
and decreased cerebral edema. Along with downregulation of
pro-apoptotic proteins, these findings suggest that ANXA1sp
treatment offers an element of neuroprotection.
Modulation of protein acetylation is emerging as a therapeutic
strategy to create a pro-survival and anti-inflammatory
phenotype in various shock states, including lethal HS (Li and
Alam, 2011). Intriguingly, promoting histone acetylation via
administration of the histone deacetylase (HDAC) inhibitor
valproic acid has been shown to decrease neuronal apoptosis,
neuroinflammation, and brain lesion size while improving neural
plasticity and resulting in faster neurocognitive and neurologic
recovery in pre-clinical models of traumatic brain injury, HS,
and polytrauma (Nikolian et al., 2017, 2018; Chang et al.,
2019). An imbalance in histone acetyltransferase/deacetylase
activity has been reported in both HS (Lin et al., 2006)
and neurodegeneration (Rouaux et al., 2003). Valproic acid
administration results in epigenetic and posttranslational
modifications that induce differential gene expression (Dekker
et al., 2014; Bambakidis et al., 2016), metabolic changes
(Hwabejire et al., 2013) and alterations of the proteome. It
appears that promoting acetylation of histones and other target
transcription factors through the use of HDAC inhibitors (like
valproic acid), as well as promoting mitochondrial protein
deacetylation via induction of SIRT3 (in this study using
ANXA1sp) can both exert neuroprotective effects in the setting
of lethal HS. The precise mechanisms by which modulation
of protein acetylation results in attenuation or resolution of
neuroinflammation remain to be elucidated.
We found that ANXA1sp treatment promoted cerebral
autophagy following EPR. This was accompanied by increased
SIRT3 protein expression, reduced cell apoptosis and improved
neuro severity scores. Importantly, upregulation of SIRT3 in
response to ANXA1sp treatment was associated with increased
expression of LC3II and a reduced level of p62/SQSTM1,
indicating increased autophagic flux (Figure 7). These results
are consistent with previous reports implicating SIRT3 as an
activator of autophagy in neuronal cells (Dai et al., 2017; Yan
et al., 2018) and macrophages (Liu et al., 2018) under various
stress conditions in vitro, and in vivo studies showing sirtuin
activation to be protective in spinal cord injury, brain trauma, and
cerebral ischemia (He et al., 2017; Zhao et al., 2017). A schematic
representation of the relationships between ANXA1sp, the SIRT3
pathway and neuroinflammation in the context of cerebral I/RI is
shown in Figure 8.
Although the therapeutic effects of hypothermia in HS in
general, and those of EPR for exsanguinating cardiac arrest
in particular, have been previously reported in large animal
experiments (Alam et al., 2002, 2004, 2005, 2006a,b; Chen et al.,
2005; Wu et al., 2006), benefits of the clinically realistic rat
model described in this study include lower costs to test efficacy
of selective pharmacological neuroprotective interventions (such
as the pro-resolving ANXA1sp) in enhancing clinical outcomes
after EPR, as well as availability of molecular biology tools
to understand the mechanisms at play. To increase clinical
relevance, we modified previously described rodent models of
EPR (Drabek et al., 2007a,b) in several ways: first, we introduced
a prolonged period of HS followed by induction of fibrillatory
cardiac arrest; second, we rapidly induced profound hypothermia
via aortic flushing of a relatively low volume (1.5–2 fold the
estimated blood volume) of ice-cold saline-based solution using a
light weight cycling system at 20 ml/min; finally, we re-transfused
salvaged autologous blood during resuscitation, thereby avoiding
additional confounding effects from exposure to allogeneic
blood transfusions. In this severe model, administration of a
pro-resolving ANXA1 bioactive peptide during EPR was superior
to EPR alone in attenuating neuroinflammation, increasing
pro-survival protein expression and autophagic flux.
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FIGURE 8 | Simplified diagram of the protective effects of ANXA1sp following cerebral ischemia-reperfusion injury associated with experimental exsanguinating
cardiac arrest (CA) and emergent preservation and resuscitation (EPR).
Several limitations of this study follow. HS was achieved
by closely controlled exsanguination of blood, which was
salvaged and re-transfused. Although we designed the model
to closely mimic the clinical scenario, HS inevitably requires
surgical bleeding control and transfusion of allogeneic blood
products, which would significantly amplify the inflammatory
response. Rats serve as imperfect surrogates for human
subjects, and only male young adult animals were used. An
injured but un-resuscitated control group was not used,
as the survival without resuscitation is extremely poor.
Instead, we used a naïve uninjured control group, to allow
assessing whether ANXA1sp effects are restorative or de novo.
We have not measured directly markers of resolution of
inflammation (neutrophil apoptosis/efferocytosis, functional
macrophage switches), or microglial activation. However,
microglial activation was attenuated by ANXA1sp treatment
in our previously reported rat deep hypothermic circulatory
arrest study (Zhang et al., 2017). This study focuses on
ANXA1sp-induced upregulation of the SIRT3 pathway,
and thus we have not explored the traditional mechanisms
implicated in the pro-resolving effects of Annexin A1 and
its bioactive peptides (via the FPR2/ALX receptor pathway).
The neuroinflammatory response to hypothermic cardiac
arrest is not uniform, displaying important spatio-temporal
differences between brain regions (Drabek et al., 2015). Our
investigation focused on the cortex and hippocampus as two
vulnerable brain regions, but other areas displaying robust
early neuroinflammatory responses (e.g., the striatum) were
not studied. Temporally, our observation period was limited to
24 h, and longer-term evaluations are required to fully assess
ANXA1sp’s protective effects, including neurocognitive tests.
Although previous reports from experimental focal cerebral
I/RI in the rat suggest neutrophil accumulation in the infarct
area (which correlates closely with cortical lesion size) to be
maximal at 24 h post-reperfusion (Zhang et al., 1994), it should
be noted that our results may represent a delay rather than
elimination of neuronal death in the selectively vulnerable brain
regions studied.
CONCLUSION
Using a clinically relevant rodent model of lethal HS and
EPR-induced acute neuroinflammation, we show that
administration of a pro-resolving ANXA1 peptide mimetic
results in a pro-survival phenotype with attenuated cortical cell
death, reduction of several common functional biomarkers of
neuroinflammation (HMGB1, IL-6, and TNFα), and improved
early neurological outcomes, compared to induction of
profound hypothermia (EPR) alone. The protective effects were
associated with increased expression of SIRT3 and corresponding
upregulation of the FOXO3a-MnSOD antioxidant pathway. In
addition, we note increased cerebral autophagy in ANXA1sp
treated animals. Further studies need to refine the mechanisms
involved and evaluate the use of SIRT3-activating drugs to
resolve acute neuroinflammation and attenuate the uncontrolled
production of ROS by activated microglia, as well as the
long-term benefits of the proposed therapeutics.
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